Drug Type Chemical drugs, Fluorescent dyes |
Synonyms NY-FR-007 |
Target |
Action modulators |
Mechanism FOLR1 modulators(Folate receptor alpha modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Cancer | Phase 2 | China | 05 Aug 2025 | |
Contrast agents | IND Approval | United States | 31 Dec 2024 |